EMILY BENFIELD: Open Payments
NPI 1710438486 · NEWLAND, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 38 payments from 12 companies in 2025. Trend: 2023 $806 · 2024 $953 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $262 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $124 |
| Lilly USA, LLC | 5 | $85 |
| PFIZER INC. | 3 | $54 |
| Novo Nordisk Inc | 3 | $52 |
| ABBVIE INC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: BREZTRI, Kerendia, MOUNJARO, AIRSUPRA, JARDIANCE, ELIQUIS, VRAYLAR, REXULTI.
Industry payments across NC — which companies pay providers there.
